Anokion is a developer of antigen-specific immunotherapy designed to develop services for antigen-specific immune tolerance. The company's immunotherapy focused on both prevalent and rare autoimmune diseases including celiac disease, multiple sclerosis, and type 1 diabetes which features proteins or antigens that are engineered to deliver precise therapy without the side effects, enabling doctors to improve the patients' treatment and outcomes of autoimmune disease.
Parent CompanyCelgene
HQEcublens, CH
Cybersecurity ratingAMore
Anokion was founded in 2010 and is headquartered in Ecublens, CH
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Anokion

Mike Clayman

Mike Clayman

Deborah Geraghty

Deborah Geraghty

Chief Executive Officer and President
Jeffrey Hubbell

Jeffrey Hubbell

Patricia L. Allen

Patricia L. Allen

Raj Manchanda

Raj Manchanda

Chief Development Officer
Stephan Kontos

Stephan Kontos

Co-Founder, Chief Scientific Officer
Show more

Anokion Office Locations

Anokion has offices in Ecublens and Cambridge
Ecublens, CH (HQ)
Chemin de la Dent d'Oche 1 A
Cambridge, MA, US
50 Hampshire St Suite 402, 4th floor
Show all (2)

Anokion Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$77.6 m


In total, Anokion had raised $77.6 m. Anokion is a subsidiary of Celgene

Anokion Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Anokion Online and Social Media Presence

Embed Graph

Anokion News and Updates

Beyond Celiac Drives Patient Recruitment for Promising Anokion Clinical Trial

Celiac Disease Community an Integral Part of Research into Immune Tolerance Treatment Celiac Disease Community an Integral Part of Research into Immune Tolerance Treatment

Anokion Frequently Asked Questions

  • When was Anokion founded?

    Anokion was founded in 2010.

  • Who are Anokion key executives?

    Anokion's key executives are Mike Clayman, Deborah Geraghty and Jeffrey Hubbell.

  • How many employees does Anokion have?

    Anokion has 37 employees.

  • Who are Anokion competitors?

    Competitors of Anokion include Fulcrum Therapeutics, Novadip Biosciences and Themis Bioscience.

  • Where is Anokion headquarters?

    Anokion headquarters is located at Chemin de la Dent d'Oche 1 A, Ecublens.

  • Where are Anokion offices?

    Anokion has offices in Ecublens and Cambridge.

  • How many offices does Anokion have?

    Anokion has 2 offices.